This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider.
Nicholas J. Silvestri, MD: Welcome to Medscape InDiscussion: Myasthenia Gravisor MG for short. I'm your host, Dr Nick Silvestri. This is the sixth and final episode of our first season of this podcast, and we've saved the best for last: managing patients with MG in the primary care setting. Ideally, what role do primary care physicians (PCPs) play in the management of MG? With a lack of specialist availability, should PCPs manage most care other than diagnosis and treatment planning? And what are the key guardrails to know? For expert guidance on these questions, we've invited Dr Michael Hehir, the James F. Howard II, MD Professor of neuromuscular disorders in the Department of Neurological Sciences at the Larner College of Medicine, and division chief of neuromuscular medicine at the University of Vermont Medical Center in Burlington, Vermont. In addition to his work at University of Vermont, Dr Hehir served and continues to serve in leadership roles with the Myasthenia Gravis Foundation of America, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the Neuromuscular Study Group.
